Suda
Osborne · Founded 1982
About Suda
Suda Ltd (ASX: SUD) is a drug delivery company utilising proprietary oro-mucosal drug delivery technology to develop low-risk, innovative pharmaceuticals that improve the health and lifestyle of patients. The many potential benefits of administering drugs through the oral mucosa, which is the moist lining of the oral cavity (ie: cheeks, tongue, gums and palate), include ease of use, lower dosage, reduced side effects and faster response time.
Company Facts
- Founded: 1982
- Legal name: Suda Limited
- Operating status: IPO
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: Less than $1M
- Total funding: $9.5M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jun 2019)
- Website: sudaltd.com.au
- Phone: 61 8 6142 5555
Social Profiles
Canonical: https://fsome.com/organization/suda-8448063 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.